A prescription for the US FDA for the regulation of health misinformation

被引：3

作者：

Kadakia, Kushal T. ^{[1
]}

Beckman, Adam L. ^{[1
,2
]}

Krumholz, Harlan M. ^{[3
,4
,5
]}

机构：

[1] Harvard Med Sch, Boston, MA USA

[2] Harvard Sch Business, Boston, MA USA

[3] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA

[4] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA

[5] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA

来源：

NATURE MEDICINE | 2023年 / 29卷 / 03期

关键词：

D O I：

10.1038/s41591-022-02172-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The US Food and Drug Administration should address health misinformation through existing and new regulatory approaches, including modernizing product labeling, investing in infodemic surveillance and addressing the roles of the internet and social media.

引用

页码：525 / 527

页数：3

共 50 条

[1] A prescription for the US FDA for the regulation of health misinformation
Kushal T. Kadakia
Adam L. Beckman
Harlan M. Krumholz
Nature Medicine, 2023, 29 : 525 - 527
[2] FDA Regulation of Prescription Drugs
Gassman, Audrey L.
Nguyen, Christine P.
Joffe, Hylton V.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07): : 674 - 682
[3] FDA REGULATION OF VETERINARY PRESCRIPTION DRUGS
STEFAN, GE
BEAULIEU, AJ
BALLITCH, EJ
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1986, 189 (05) : 513 - 517
[4] FDA regulation of prescription of controlled substances
Reuter, N
MARIHUANA AND MEDICINE, 1999, : 751 - 755
[5] FDA REGULATION OF PRESCRIPTION DRUG ADVERTISING
PECK, CC
RHEINSTEIN, PH
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (18): : 2424 - 2425
[6] FDA AND THE REGULATION OF PRESCRIPTION DRUG ADVERTISING AND PROMOTION
MILLSTEIN, LG
JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS, 1985, 36 (05): : 377 - 377
[7] US FDA revises prescription drug information format
Reactions Weekly, 2006, 1086 (1) : 3 - 3
[8] US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity
G Gomez
F C Stanford
International Journal of Obesity, 2018, 42 : 495 - 500
[9] US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity
Gomez, G.
Stanford, F. C.
INTERNATIONAL JOURNAL OF OBESITY, 2018, 42 (03) : 495 - 500
[10] FDA Regulation of Tobacco Products in the US
Zeller, Mitch
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S98 - S98

← 1 2 3 4 5 →